BIO-TECHNOLOGIES CORP
Action · US09073M1045 · TECH · A12ENG (XNAS)
51,49 USD
11.06.2025 20:06
Cours actuels de BIO-TECHNOLOGIES CORP
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
TECH
|
USD
|
11.06.2025 20:06
|
51,49 USD
| 51,40 USD
+0,18 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 6,58 % | 3,10 % | -11,94 % | -32,96 % | -33,03 % | -14,91 % |
Company Profile for BIO-TECHNOLOGIES CORP Share
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Invested Funds
The following funds have invested in: BIO-TECHNOLOGIES CORP invested:
Fund | Vol. in million 7.307,30 | Percentage (%) 0,46 % |
Fund | Vol. in million 40,33 | Percentage (%) 0,31 % |
Fund | Vol. in million 512,38 | Percentage (%) 0,31 % |
Fund | Vol. in million 928,43 | Percentage (%) 0,25 % |
Fund | Vol. in million 551,14 | Percentage (%) 0,17 % |
Company Data
Name BIO-TECHNOLOGIES CORP
Company Bio-Techne Corporation
Symbol TECH
Website
https://www.bio-techne.com
Primary Exchange
NASDAQ

WKN A12ENG
ISIN US09073M1045
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Kim Kelderman
Market Capitalization 8 Mrd.
Country United States of America
Currency USD
Employees 3,1 T
Address 614 McKinley Place N.E., 55413 Minneapolis
IPO Date 1989-02-09
Dividends from 'BIO-TECHNOLOGIES CORP'
Ex-Date | Dividend per Share |
---|---|
19.05.2025 | 0,08 USD |
14.02.2025 | 0,08 USD |
08.11.2024 | 0,08 USD |
19.08.2024 | 0,08 USD |
10.05.2024 | 0,08 USD |
09.02.2024 | 0,08 USD |
09.11.2023 | 0,08 USD |
17.08.2023 | 0,08 USD |
12.05.2023 | 0,08 USD |
10.02.2023 | 0,08 USD |
Stock Splits
Date | Split |
---|---|
30.11.2022 | 4:1 |
04.12.2000 | 2:1 |
18.11.1997 | 2:1 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | TE1.F |
NASDAQ | TECH |
More Shares
Investors who BIO-TECHNOLOGIES CORP hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.